The Lottery Corporation Limited (ASX: TLC) has announced that Managing Director and CEO, Sue van der Merwe, will retire by the end of calendar year 2025, bringing to a close…
James Hardie to Acquire AZEK in US$8.75B Deal, Creating a Building Products Powerhouse
In a bold move to reshape the building products landscape, James Hardie Industries (ASX/NYSE: JHX) has struck a US$8.75 billion deal to acquire US-based AZEK Company Inc. (NYSE: AZEK), forming…
Emerald Resources Updates March 2025 Production Guidance
Emerald Resources (ASX: EMR) has provided a production update for the March 2025 quarter, with gold output from the Okvau Gold Mine expected to be around 20,000 ounces—slightly below initial…
Telix Wins FDA Approval for Next-Generation Prostate Cancer Imaging Agent, Gozellix®
Melbourne & Indianapolis, March 21, 2025 – Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has secured FDA approval for Gozellix®, its next-generation PSMA-PET imaging agent for prostate cancer. This milestone expands…
Sigma Delivers Strong FY25 Performance Ahead of Chemist Warehouse Merger
Sigma Healthcare Limited (ASX: SIG) has reported a strong financial performance for the full year ended 31 January 2025, marking its final standalone results before merging with Chemist Warehouse Group…
Nanosonics Secures FDA Clearance for CORIS® Infection Prevention System
Nanosonics Limited (ASX: NAN) has hit a major milestone, securing FDA De Novo clearance for CORIS®, its innovative new system designed to enhance infection prevention in hospitals. This approval marks…
Brickworks Delivers Strong Earnings Growth, Ups Dividend Again
Brickworks (ASX: BKW) has come out swinging with a solid half-year result, reporting a statutory net profit after tax (NPAT) of $21 million, a 141% increase on the prior year….
Arafura Secures Rare Earths Offtake Deal with Traxys Europe
Arafura Rare Earths (ASX: ARU) has taken another step toward securing its global supply footprint, signing a binding offtake agreement with Traxys Europe SA for NdPr oxide from the Nolans…
Myer Group’s Half-Year 2025 Results: Strategic Reset Amid Tough Market Conditions
Myer Holdings Limited (ASX: MYR) has reported its half-year results for FY25, highlighting steady sales growth despite a challenging economic environment and the company’s ongoing strategic transformation. Navigating Economic Headwinds…
Imugene’s Azer-cel Granted FDA Fast Track Designation for Blood Cancer
Sydney, 19 March 2025 – Imugene Limited (ASX: IMU) has achieved a major milestone with the US Food and Drug Administration (FDA) granting Fast Track Designation for its allogeneic CAR…